Yu‐Pei Liao

7.6k total citations · 2 hit papers
69 papers, 6.1k citations indexed

About

Yu‐Pei Liao is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Yu‐Pei Liao has authored 69 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Immunology and 19 papers in Oncology. Recurrent topics in Yu‐Pei Liao's work include Nanoparticles: synthesis and applications (13 papers), Immunotherapy and Immune Responses (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Yu‐Pei Liao is often cited by papers focused on Nanoparticles: synthesis and applications (13 papers), Immunotherapy and Immune Responses (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Yu‐Pei Liao collaborates with scholars based in United States, China and Taiwan. Yu‐Pei Liao's co-authors include André E. Nel, Chong Hyun Chang, Tian Xia, Huan Meng, Bingbing Sun, Zhaoxia Ji, Xiangsheng Liu, Meiying Wang, Ruibin Li and Haiyuan Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Yu‐Pei Liao

68 papers receiving 6.0k citations

Hit Papers

Use of Metal Oxide Nanopa... 2012 2026 2016 2021 2012 2017 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Use of Metal Oxide Nanoparticle Band Gap To Develop a Predictive Paradigm for Oxidative Stress and Acute Pulmonary Inflammation
    2012 680 citations Zhaoxia Ji, Tian Xia et al. ACS Nano profile →
  2. Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
    2017 399 citations Jianqin Lu, Xiangsheng Liu et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Pei Liao United States 41 2.2k 2.1k 1.6k 1.5k 1.1k 69 6.1k
Chong Hyun Chang United States 50 3.3k 1.5× 2.9k 1.4× 1.6k 1.0× 1.1k 0.7× 1.5k 1.4× 85 7.2k
Yuri Volkov Ireland 40 2.0k 0.9× 1.8k 0.8× 1.3k 0.8× 520 0.4× 1.1k 1.0× 110 5.1k
M. Laird Forrest United States 37 1.5k 0.7× 1.8k 0.9× 2.5k 1.6× 535 0.4× 1.7k 1.6× 109 6.5k
Hongzhang Deng China 39 1.8k 0.8× 3.4k 1.6× 1.9k 1.2× 941 0.6× 1.6k 1.5× 81 5.9k
Shin‐ichi Tsunoda Japan 41 1.0k 0.5× 717 0.3× 2.0k 1.3× 952 0.7× 619 0.6× 194 4.9k
Shirley K. Knauer Germany 39 1.6k 0.8× 1.6k 0.8× 3.9k 2.5× 610 0.4× 2.4k 2.2× 150 7.6k
Zhiqiang Yu China 54 2.7k 1.2× 3.5k 1.6× 3.0k 1.9× 521 0.4× 2.2k 2.0× 185 8.3k
Ravi Singh United States 39 2.2k 1.0× 2.8k 1.3× 2.5k 1.6× 445 0.3× 996 0.9× 84 6.5k
Adriele Prina‐Mello Ireland 42 1.7k 0.8× 2.3k 1.1× 1.4k 0.9× 297 0.2× 1.6k 1.5× 133 5.6k
Jinjin Shi China 49 1.9k 0.9× 3.4k 1.6× 2.3k 1.4× 465 0.3× 1.6k 1.5× 189 6.8k

Countries citing papers authored by Yu‐Pei Liao

Since Specialization
Citations

This map shows the geographic impact of Yu‐Pei Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Pei Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Pei Liao more than expected).

Fields of papers citing papers by Yu‐Pei Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Pei Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Pei Liao. The network helps show where Yu‐Pei Liao may publish in the future.

Co-authorship network of co-authors of Yu‐Pei Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Pei Liao. A scholar is included among the top collaborators of Yu‐Pei Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Pei Liao. Yu‐Pei Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Lijia, Xiang Wang, Yu‐Pei Liao, & André E. Nel. (2025). KRAS mRNA Spleen‐Targeting Lipid Nanoparticles Synergize with Irinotecan Silicasomes to Robustly Augment the Cancer Immunity Cycle in Pancreatic Cancer. Advanced Science. 12(34). e04886–e04886. 1 indexed citations
2.
3.
Xu, Xiao, Xiang Wang, Yu‐Pei Liao, Lijia Luo, & André E. Nel. (2025). Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA. ACS Nano. 19(9). 8579–8594. 12 indexed citations
4.
Zhang, Chu, Yu‐Pei Liao, Hai‐Jing Zhong, et al.. (2024). Apigenin promotes apoptosis of 4T1 cells through PI3K/AKT/Nrf2 pathway and improves tumor immune microenvironment in vivo. Toxicology Research. 13(1). tfae011–tfae011. 7 indexed citations
5.
Luo, Lijia, Xiang Wang, Yu‐Pei Liao, et al.. (2023). Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering nintedanib, a protein tyrosine kinase inhibitor. Nano Today. 54. 102058–102058. 8 indexed citations
6.
Chattopadhyay, Saborni, Yu‐Pei Liao, Xiang Wang, & André E. Nel. (2023). Use of Stromal Intervention and Exogenous Neoantigen Vaccination to Boost Pancreatic Cancer Chemo-Immunotherapy by Nanocarriers. Bioengineering. 10(10). 1205–1205. 7 indexed citations
7.
Luo, Lijia, Xiang Wang, Yu‐Pei Liao, Chong Hyun Chang, & André E. Nel. (2022). Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy. ACS Nano. 16(8). 13168–13182. 51 indexed citations
8.
Cao, Wei, Xiang Wang, Jiulong Li, et al.. (2021). NLRP3 inflammasome activation determines the fibrogenic potential of PM2.5 air pollution particles in the lung. Journal of Environmental Sciences. 111. 429–441. 32 indexed citations
9.
Liao, Yu‐Pei, et al.. (2020). HMGB1 in Radiotherapy: A Two Headed Signal Regulating Tumor Radiosensitivity and Immunity. SHILAP Revista de lepidopterología. 1 indexed citations
10.
11.
12.
Liu, Xiangsheng, Jinhong Jiang, Ryan Chan, et al.. (2018). Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer. ACS Nano. 13(1). 38–53. 106 indexed citations
13.
Ji, Ying, Xiangsheng Liu, Max T. Huang, et al.. (2018). Development of self-assembled multi-arm polyrotaxanes nanocarriers for systemic plasmid delivery in vivo. Biomaterials. 192. 416–428. 35 indexed citations
14.
Lu, Jianqin, Xiangsheng Liu, Yu‐Pei Liao, et al.. (2017). Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression. Nature Communications. 8(1). 1811–1811. 399 indexed citations breakdown →
15.
Sun, Bingbing, Zhaoxia Ji, Yu‐Pei Liao, et al.. (2017). Enhanced Immune Adjuvant Activity of Aluminum Oxyhydroxide Nanorods through Cationic Surface Functionalization. ACS Applied Materials & Interfaces. 9(26). 21697–21705. 53 indexed citations
16.
Wang, Xiang, Nikhita D. Mansukhani, Linda M. Guiney, et al.. (2016). Toxicological Profiling of Highly Purified Metallic and Semiconducting Single-Walled Carbon Nanotubes in the Rodent Lung and E. coli. ACS Nano. 10(6). 6008–6019. 37 indexed citations
17.
Iwamoto, Keisuke S., Yu‐Pei Liao, John J. DeMarco, et al.. (2010). Radiation Enhances Regulatory T Cell Representation. International Journal of Radiation Oncology*Biology*Physics. 81(4). 1128–1135. 341 indexed citations
18.
Huang, Siyuan, Yu‐Pei Liao, Dörthe Schaue, et al.. (2008). FLT-PET Imaging of Radiation Responses in Murine Tumors. Molecular Imaging and Biology. 10(6). 325–334. 21 indexed citations
19.
Liao, Yu‐Pei, Lisa H. Butterfield, Wilson S. Meng, Antoni Ribas, & William H. McBride. (2004). Human glioma cell models resistant to alloreactive cytotoxic T lymphocytes. Cancer Research. 64. 159–159. 1 indexed citations
20.
Liao, Yu‐Pei, Chun‐Chieh Wang, Lisa H. Butterfield, et al.. (2004). Ionizing Radiation Affects Human MART-1 Melanoma Antigen Processing and Presentation by Dendritic Cells. The Journal of Immunology. 173(4). 2462–2469. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chong Hyun Chang Breakdown of academic impact, for papers by Yuri Volkov Breakdown of academic impact, for papers by M. Laird Forrest Breakdown of academic impact, for papers by Hongzhang Deng Breakdown of academic impact, for papers by Shin‐ichi Tsunoda Breakdown of academic impact, for papers by Shirley K. Knauer Breakdown of academic impact, for papers by Zhiqiang Yu Breakdown of academic impact, for papers by Ravi Singh Breakdown of academic impact, for papers by Adriele Prina‐Mello Breakdown of academic impact, for papers by Jinjin Shi
Rankless by CCL
2026